Experimental Drug Repairs DNA Damage in Earliest Stages of Alzheimer's

Researchers say an experimental drug may repair DNA damage at the earliest stages of Alzheimer's disease and has already passed safety trials, raising hopes for a treatment that targets the condition before symptoms take hold. If confirmed in larger studies, the approach could shift Alzheimer's care toward prevention rather than management. The findings add to a growing wave of research seeking to slow or reverse neurodegeneration.